NOninVasive Intracranial PrEssure from Transcranial DoppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
Launched by EMORY UNIVERSITY · Sep 11, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better monitor brain health in patients who have suffered serious injuries or conditions affecting the brain, such as traumatic brain injury, strokes, or bleeding in the brain. Researchers at several medical centers, including UCSF and Duke University, will use a special non-invasive device called Transcranial Doppler (TCD) to measure blood flow in the brain. By collecting data from patients with these conditions, the goal is to develop new ways to monitor brain pressure and understand how the brain responds to different treatments over time.
Eligible participants are adults aged 18 and older who already have a device that can monitor brain pressure continuously for at least 30 minutes. Those with unstable medical conditions or certain types of head injuries may not be able to take part in the trial. If you join, you can expect to have your brain's blood flow measured for up to an hour, which will help researchers create better monitoring tools for future brain care. This study is important because it aims to gather information that could lead to improved care for patients with serious brain issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female subjects 18 years of age and older
- • 2. Subjects who have an ICP Monitoring device
- Exclusion Criteria:
- • 1. Unstable medical illness such as recordings might interfere with medical care.
- • 2. Subjects that don't have a viable temporal window to insonate the MCA.
- • 3. Subjects that have skull fractures that the attending or study investigators believe participation would add clinical risk to the subject.
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Atlanta, Georgia, United States
Durham, North Carolina, United States
Davis, California, United States
Patients applied
Trial Officials
Xiao Hu
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials